Ironwood Pharmaceuticals (IRWD) Non-cash Items (2010 - 2025)

Ironwood Pharmaceuticals has disclosed Non-cash Items across 16 years of filings, most recently posting $3.4 million for Q4 2025.

• Non-cash Items for Q4 2025 came in at $3.4 million, down 25.13% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.4 million (down 25.13% YoY), and the FY2025 annual result was $3.4 million, down 25.13% from the prior year.
• Non-cash Items came in at $3.4 million for Q4 2025 at Ironwood Pharmaceuticals, down from $4.5 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $5.8 million in Q4 2022 to a low of $2.9 million in Q4 2023.
• The 5-year median for Non-cash Items is $4.5 million (2021), against an average of $4.2 million.
• Across the five-year window, Non-cash Items slumped 49.53% in 2023 and soared 55.49% in 2024, its largest moves.
• Ironwood Pharmaceuticals' Non-cash Items stood at $4.5 million in 2021, then increased by 27.78% to $5.8 million in 2022, then slumped by 49.53% to $2.9 million in 2023, then jumped by 55.49% to $4.5 million in 2024, then declined by 25.13% to $3.4 million in 2025.
• The last three Non-cash Items figures came in at $3.4 million (Q4 2025), $4.5 million (Q4 2024), and $2.9 million (Q4 2023), per Business Quant data.